Type I and type III collagen metabolites in adult osteosarcoma patients.

Three biochemical markers of collagen metabolism were measured in 39 osteosarcoma patients. The pretreatment values did not predict outcome, and the markers showed no consistent change upon development of metastases. Both the age of the patients and the multimodality therapy affected the collagen me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiklund, T., Blomqvist, C., Risteli, L., Risteli, J., Karaharju, E., Elomaa, I.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074279/
https://www.ncbi.nlm.nih.gov/pubmed/8554970
_version_ 1782137933887700992
author Wiklund, T.
Blomqvist, C.
Risteli, L.
Risteli, J.
Karaharju, E.
Elomaa, I.
author_facet Wiklund, T.
Blomqvist, C.
Risteli, L.
Risteli, J.
Karaharju, E.
Elomaa, I.
author_sort Wiklund, T.
collection PubMed
description Three biochemical markers of collagen metabolism were measured in 39 osteosarcoma patients. The pretreatment values did not predict outcome, and the markers showed no consistent change upon development of metastases. Both the age of the patients and the multimodality therapy affected the collagen metabolites. These findings emphasise the need for cautious interpretation of tumour-associated markers.
format Text
id pubmed-2074279
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20742792009-09-10 Type I and type III collagen metabolites in adult osteosarcoma patients. Wiklund, T. Blomqvist, C. Risteli, L. Risteli, J. Karaharju, E. Elomaa, I. Br J Cancer Research Article Three biochemical markers of collagen metabolism were measured in 39 osteosarcoma patients. The pretreatment values did not predict outcome, and the markers showed no consistent change upon development of metastases. Both the age of the patients and the multimodality therapy affected the collagen metabolites. These findings emphasise the need for cautious interpretation of tumour-associated markers. Nature Publishing Group 1996-01 /pmc/articles/PMC2074279/ /pubmed/8554970 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Wiklund, T.
Blomqvist, C.
Risteli, L.
Risteli, J.
Karaharju, E.
Elomaa, I.
Type I and type III collagen metabolites in adult osteosarcoma patients.
title Type I and type III collagen metabolites in adult osteosarcoma patients.
title_full Type I and type III collagen metabolites in adult osteosarcoma patients.
title_fullStr Type I and type III collagen metabolites in adult osteosarcoma patients.
title_full_unstemmed Type I and type III collagen metabolites in adult osteosarcoma patients.
title_short Type I and type III collagen metabolites in adult osteosarcoma patients.
title_sort type i and type iii collagen metabolites in adult osteosarcoma patients.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074279/
https://www.ncbi.nlm.nih.gov/pubmed/8554970
work_keys_str_mv AT wiklundt typeiandtypeiiicollagenmetabolitesinadultosteosarcomapatients
AT blomqvistc typeiandtypeiiicollagenmetabolitesinadultosteosarcomapatients
AT ristelil typeiandtypeiiicollagenmetabolitesinadultosteosarcomapatients
AT ristelij typeiandtypeiiicollagenmetabolitesinadultosteosarcomapatients
AT karaharjue typeiandtypeiiicollagenmetabolitesinadultosteosarcomapatients
AT elomaai typeiandtypeiiicollagenmetabolitesinadultosteosarcomapatients

Ejemplares similares